A grant of €466,500 ($509,500) was awarded to Univercells, following recommendations from the DG06 Economy, Employement and Research branch, to fund part of a two-year research project, UNIVERSCALE, to reduce the cost of vaccine manufacturing. It covers 70% of the budgeted costs of the industrial research part of the project.
The UNIVERSCALE project began in 2013 and is now in its final stages, to be completed by the end of 2015. It aims to secure proof of concept for the development of an integrated and continuous in-line manufacturing method for viral antigens (culture, expression and purification). The company’s goal is to reduce the cost of manufacturing vaccines by simplifying the production processes.
Company plans are to develop a highly productive biomanufacturing platform based on the results of the industrial research that the grant has funded.